Follow-up
Further Inpatient Care
- Many physicians admit patients who have corneal involvement for intravenous antibiotics. They can be discharged once the infection is under control and the corneal infection is improving.
Further Outpatient Care
- Patients require close follow-up care to ensure that the infection is improving and the cornea is not becoming involved.
Deterrence/Prevention
- Safe sexual practices, including condom use
Complications
- Disseminated systemic infection, meningitis, corneal ulceration, corneal perforation, and endophthalmitis
Prognosis
- Prognosis is excellent if treated quickly; prognosis is poor if untreated or treated late.
Patient Education
- Educate patients about the risks of STDs and safe sexual practices.
- For excellent patient education resources, visit eMedicine's Sexually Transmitted Diseases Center. Also, see eMedicine's patient education article Gonorrhea.
Miscellaneous
Medicolegal Pitfalls
- Failure to check sexual partners and evaluate them for other STDs
Special Concerns
- Check patient and sexual partners to make ensure that no other STDs are present.
More on Gonococcus |
| Overview: Gonococcus |
| Differential Diagnoses & Workup: Gonococcus |
| Treatment & Medication: Gonococcus |
Follow-up: Gonococcus |
| References |
| « Previous Page |
References
Centers for Disease Control and Prevention (CDC). Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep. Apr 13 2007;56(14):332-6. [Medline].
Centers for Disease Control and Prevention (CDC). Updated recommended treatment regimens for gonococcal infections and associated conditions - United States, April 2007. CDC. Available at http://www.cdc.gov/std/treatment/2006/updated-regimens.htm. Accessed July 17, 2007.
Harkins T. Sexually transmitted diseases. Optom Clin. 1994;3(4):129-56. [Medline].
Isenberg SJ, Apt L, Campeas D. Ocular applications of povidone-iodine. Dermatology. 2002;204 Suppl 1:92-5. [Medline].
Kestelyn P, Bogaerts J, Meheus A. Gonorrheal keratoconjunctivitis in African adults. Sex Transm Dis. Oct-Dec 1987;14(4):191-4. [Medline].
Lee JS, Choi HY, Lee JE, Lee SH, Oum BS. Gonococcal keratoconjunctivitis in adults. Eye. Sep 2002;16(5):646-9. [Medline].
Reed K, Jones MW. PPNG conjunctivitis. J Am Optom Assoc. Jun 1984;55(6):425-7. [Medline].
Schwab L, Tizazu T. Destructive epidemic Neisseria gonorrheae keratoconjunctivitis in African adults. Br J Ophthalmol. Jul 1985;69(7):525-8. [Medline].
Tight RR. Gonococcal conjunctivitis. JAMA. May 14 1982;247(18):2499. [Medline].
Ullman S, Roussel TJ, Culbertson WW, Forster RK, Alfonso E, Mendelsohn AD, et al. Neisseria gonorrhoeae keratoconjunctivitis. Ophthalmology. May 1987;94(5):525-31. [Medline].
Ullman S, Roussel TJ, Forster RK. Gonococcal keratoconjunctivitis. Surv Ophthalmol. Nov-Dec 1987;32(3):199-208. [Medline].
Wan WL, Farkas GC, May WN, Robin JB. The clinical characteristics and course of adult gonococcal conjunctivitis. Am J Ophthalmol. Nov 15 1986;102(5):575-83. [Medline].
Zajdowicz TR, Kerbs SB, Berg SW, Harrison WO. Laboratory-acquired gonococcal conjunctivitis: successful treatment with single-dose ceftriaxone. Sex Transm Dis. Jan-Mar 1984;11(1):28-9. [Medline].
Further Reading
Keywords
gonorrhea, Neisseria gonorrhoeae, N gonorrhoeae, hyperacute conjunctivitis, sexually transmitted disease, STD
Follow-up: Gonococcus